Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tony Badrick

Showing results (11-20 of 202) with videos related to

Pageof 21
Sort By:
Clinical Chemistry and Laboratory Medicine|March 25, 2019
Letter to the Editor on article Dimech W, Karakaltsas M, Vincini G. Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing. Clin Chem Lab Med 2018;56:1970-8Tony Badrick, Curtis Parvin
Biochemia Medica|April 16, 2020
Changes in error rates in the Australian key incident monitoring and management system programStephanie Gay, Tony Badrick
Pathology|April 20, 2019
Is total iron binding capacity (TIBC) calculation correct?Geetha Rathnayake, Tony Badrick
Clinical Chemistry and Laboratory Medicine|October 24, 2012
The impact on costs and efficiency of reducing the number of collected tubesPeter Hobson, Tony Badrick
Indian Journal of Clinical Biochemistry : IJCB|January 16, 2014
The Uncertainty of the eGFRTony Badrick, Peter Turner
Clinical Biochemistry|October 16, 2023
Methods for determining clinical utilityFrancis Bowling, Tony Badrick
Clinical Chemistry and Laboratory Medicine|May 16, 2020
Harmonising EQA schemes the next frontier: challenging the status quoTony Badrick, Anne Stavelin
Indian Journal of Clinical Biochemistry : IJCB|February 9, 2016
Review and Recommendations for the Component Tests in the Liver Function Test ProfileTony Badrick, Peter Turner
The Medical Journal of Australia|October 24, 2020
The carbon footprint of pathology testingTina Yen, Tony Badrick
Clinical Chemistry and Laboratory Medicine|June 10, 2024
Six Sigma - is it time to re-evaluate its value in laboratory medicine?Tony Badrick, Elvar Theodorsson
Pageof 21

Showing results (11-20 of 202) with videos related to

Sort By:
Pageof 21
Clinical Chemistry and Laboratory Medicine|March 25, 2019
Letter to the Editor on article Dimech W, Karakaltsas M, Vincini G. Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing. Clin Chem Lab Med 2018;56:1970-8Tony Badrick, Curtis Parvin
Biochemia Medica|April 16, 2020
Changes in error rates in the Australian key incident monitoring and management system programStephanie Gay, Tony Badrick
Pathology|April 20, 2019
Is total iron binding capacity (TIBC) calculation correct?Geetha Rathnayake, Tony Badrick
Clinical Chemistry and Laboratory Medicine|October 24, 2012
The impact on costs and efficiency of reducing the number of collected tubesPeter Hobson, Tony Badrick
Indian Journal of Clinical Biochemistry : IJCB|January 16, 2014
The Uncertainty of the eGFRTony Badrick, Peter Turner
Clinical Biochemistry|October 16, 2023
Methods for determining clinical utilityFrancis Bowling, Tony Badrick
Clinical Chemistry and Laboratory Medicine|May 16, 2020
Harmonising EQA schemes the next frontier: challenging the status quoTony Badrick, Anne Stavelin
Indian Journal of Clinical Biochemistry : IJCB|February 9, 2016
Review and Recommendations for the Component Tests in the Liver Function Test ProfileTony Badrick, Peter Turner
The Medical Journal of Australia|October 24, 2020
The carbon footprint of pathology testingTina Yen, Tony Badrick
Clinical Chemistry and Laboratory Medicine|June 10, 2024
Six Sigma - is it time to re-evaluate its value in laboratory medicine?Tony Badrick, Elvar Theodorsson
Pageof 21